Relay Therapeutics (RLAY) Interest & Investment Income (2020 - 2025)
Historic Interest & Investment Income for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to $6.4 million.
- Relay Therapeutics' Interest & Investment Income fell 2256.47% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year decrease of 1210.55%. This contributed to the annual value of $34.7 million for FY2024, which is 1192.14% up from last year.
- As of Q3 2025, Relay Therapeutics' Interest & Investment Income stood at $6.4 million, which was down 2256.47% from $7.1 million recorded in Q2 2025.
- Relay Therapeutics' Interest & Investment Income's 5-year high stood at $9.0 million during Q4 2024, with a 5-year trough of $157000.0 in Q3 2021.
- Over the past 5 years, Relay Therapeutics' median Interest & Investment Income value was $6.9 million (recorded in 2023), while the average stood at $5.1 million.
- Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 8196.39% in 2021, then surged by 191198.5% in 2022.
- Over the past 5 years, Relay Therapeutics' Interest & Investment Income (Quarter) stood at $267000.0 in 2021, then surged by 1911.99% to $5.4 million in 2022, then soared by 61.95% to $8.7 million in 2023, then grew by 3.15% to $9.0 million in 2024, then fell by 28.6% to $6.4 million in 2025.
- Its Interest & Investment Income was $6.4 million in Q3 2025, compared to $7.1 million in Q2 2025 and $7.8 million in Q1 2025.